Q3 FY26 Quarterly Results Investor Webinar
Filed with ASX · · 8 pages · English
Summary by 6ix AI
The company reported receiving purchase orders for multiple devices, primarily the HiRise™, and is progressing with regulatory approvals in China. Additionally, Curvebeam Ai announced the appointment of a new non-executive director with extensive experience in the orthopaedic industry. The filing also discusses ongoing collaborations and advancements in their robotic surgery systems and the BMD module for CT scans.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Curvebeam AI
- Commentary to App 4D - Dec 2025 Half Year
- Appendix 4D - Interim Financial Report - Dec 2025 Half Year
- Quarterly Activities/Appendix 4C Cash Flow Report
- Investor Webinar Presentation - Q2 FY26
- CVB Notified of China ODI Approval for Strategic Investment
Later from Curvebeam AI
- CVB Secures 5M Placement & Announces SPP
- Update Indicative Timetable for Share Purchase Plan
- Update - Proposed issue of securities - CVB
- Security Purchase Plan
- SPP Offer Opens
Follow Curvebeam AI into a list and get an email when it puts out news.
Follow Curvebeam AI